Anticancer activity and DNA-binding properties of novel cationic Pt(II) complexes

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Cancer Biology

Background:

• Platinum (Pt) complexes are crucial in cancer chemotherapy.
• Developing novel Pt complexes with improved efficacy and reduced resistance is an ongoing challenge.
• Understanding the interaction of Pt complexes with DNA is key to designing effective anticancer agents.

Purpose of the Study:

• To synthesize and evaluate the anticancer activities of three structurally related cationic Pt complexes: [Pt(ppy)(dppe)]CF3CO2 (C1), [Pt(bhq)(dppe)]CF3CO2 (C2), and [Pt(bhq)(dppf)]CF3CO2 (C3).
• To investigate the mechanism of action, including apoptosis induction and DNA binding.
• To explore structure-activity relationships for potential antitumor drug development.

Main Methods:

• Synthesis of cationic Pt complexes (C1-C3).
• Anticancer activity assessment using MTT assay against Jurkat and MCF-7 cancer cell lines.
• Apoptosis induction analysis via Acridine Orange staining and Caspase-3 activity assay.
• DNA-binding studies using UV/vis absorption spectroscopy, CD spectroscopy, fluorescence quenching (Ethidium Bromide-DNA), and gel electrophoresis.

Main Results:

• All three Pt complexes (C1-C3) exhibited significant anticancer properties.
• Acridine Orange staining indicated apoptosis induction by the complexes.
• Complex C1 specifically stimulated Caspase-3 activity in Jurkat cells.
• Spectroscopic and gel electrophoresis data suggest a mixed-binding mode of interaction between the Pt complexes and DNA.

Conclusions:

• The synthesized cationic Pt complexes possess notable anticancer potential.
• The complexes induce apoptosis, offering a mechanism for their cytotoxic effects.
• The observed DNA interaction mode provides insights for designing future Pt-based anticancer drugs.
• Controlled structural modifications can lead to potent antitumor agents capable of overcoming cellular repair mechanisms and inducing apoptosis.